Powell Ann's Form 4 filing
Bristol Myers Squibb Co (BMY) · filed Feb 8, 2023
- Accession no.
- 0000014272-23-000043
- Filed
- Feb 8, 2023
- Trade date
- Feb 6, 2023
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 1 non-derivative transaction. Open-market sales total $835.3K. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Powell AnnCIK 0001570844 | Officer (EVP, Chief Human Resources) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 6, 2023 | Common Stock, $0.10 par value | SSaleDisposed | −11,183 | $74.69F1 | −$835,258.27 | 23,043.09 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F1
The price reported reflects the weighted average sales price. The shares were sold in multiple transactions at prices ranging from $74.690 to $74.700, inclusive. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer, upon request, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.